Case report of concurrent Fabry disease and amyotrophic lateral sclerosis supports a common pathway of pathogenesis.
a Sheffield Institute for Translational Neuroscience (SITraN) , University of Sheffield and.
Alexander M
AM
Beer
a Sheffield Institute for Translational Neuroscience (SITraN) , University of Sheffield and.
Johnathan
J
Cooper-Knock
a Sheffield Institute for Translational Neuroscience (SITraN) , University of Sheffield and.
Sakina
S
Fletcher
a Sheffield Institute for Translational Neuroscience (SITraN) , University of Sheffield and.
Sian Heledd
SH
Brown-Wright
b Hull Royal Infirmary , Hull , UK.
T Pisharam
TP
Nandakumar
a Sheffield Institute for Translational Neuroscience (SITraN) , University of Sheffield and.
Pamela J
PJ
Shaw
D000328:Adult; D000690:Amyotrophic Lateral Sclerosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000473:pathology; D001343:Autophagy; D001921:Brain / Q000000981:diagnostic imaging / Q000473:pathology; D018450:Disease Progression; D004198:Disease Susceptibility; D056947:Enzyme Replacement Therapy; D000795:Fabry Disease / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008954:Models, Biological; D009046:Motor Neurons / Q000473:pathology; D018908:Muscle Weakness / Q000209:etiology; D059906:Neuroimaging; D000519:alpha-Galactosidase / Q000235:genetics* / Q000627:therapeutic use
D000519:alpha-Galactosidase